ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 556 filers reported holding ASTRAZENECA PLC in Q1 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,103,020 | -5.4% | 296,855 | +0.0% | 0.05% | +1.9% |
Q2 2023 | $21,243,694 | +3.3% | 296,824 | +0.2% | 0.05% | +1.9% |
Q1 2023 | $20,568,959 | -32.0% | 296,340 | -33.6% | 0.05% | -38.1% |
Q4 2022 | $30,251,411 | +23.6% | 446,186 | -0.0% | 0.08% | +16.7% |
Q3 2022 | $24,471,000 | -12.7% | 446,225 | +5.2% | 0.07% | -5.3% |
Q2 2022 | $28,028,000 | -36.7% | 424,223 | -36.5% | 0.08% | -24.0% |
Q1 2022 | $44,313,000 | -35.3% | 667,963 | -43.2% | 0.10% | -21.3% |
Q4 2021 | $68,498,000 | +27.0% | 1,175,935 | +30.9% | 0.13% | +23.3% |
Q3 2021 | $53,952,000 | +2.4% | 898,316 | +2.1% | 0.10% | +5.1% |
Q2 2021 | $52,706,000 | +62.2% | 879,902 | +34.6% | 0.10% | +55.6% |
Q1 2021 | $32,504,000 | +0.4% | 653,738 | +0.9% | 0.06% | -4.5% |
Q4 2020 | $32,373,000 | -16.8% | 647,615 | -8.7% | 0.07% | -27.5% |
Q3 2020 | $38,896,000 | +0.2% | 709,438 | -3.4% | 0.09% | -5.2% |
Q2 2020 | $38,835,000 | +20.1% | 734,253 | +1.4% | 0.10% | +1.1% |
Q1 2020 | $32,336,000 | +25.9% | 724,065 | +40.6% | 0.10% | +66.7% |
Q4 2019 | $25,677,000 | +104.3% | 514,985 | +82.6% | 0.06% | +83.9% |
Q3 2019 | $12,567,000 | -18.4% | 281,966 | -24.5% | 0.03% | -16.2% |
Q2 2019 | $15,409,000 | -11.1% | 373,295 | -12.9% | 0.04% | -14.0% |
Q1 2019 | $17,331,000 | -85.2% | 428,673 | -86.1% | 0.04% | -86.6% |
Q4 2018 | $117,471,000 | +21.5% | 3,092,977 | +26.6% | 0.32% | +42.2% |
Q3 2018 | $96,683,000 | -26.8% | 2,443,361 | -35.0% | 0.22% | -41.9% |
Q2 2018 | $132,009,000 | -11.4% | 3,759,882 | -11.7% | 0.39% | -10.6% |
Q1 2018 | $148,962,000 | -19.5% | 4,259,726 | -20.2% | 0.43% | -17.0% |
Q4 2017 | $185,123,000 | +2.5% | 5,334,968 | +0.0% | 0.52% | +0.8% |
Q3 2017 | $180,690,000 | +18.2% | 5,333,256 | +18.9% | 0.52% | +17.7% |
Q2 2017 | $152,885,000 | +13.4% | 4,484,770 | +3.6% | 0.44% | +14.3% |
Q1 2017 | $134,790,000 | +93.1% | 4,328,514 | +69.4% | 0.38% | +84.2% |
Q4 2016 | $69,818,000 | -45.8% | 2,555,573 | -34.8% | 0.21% | -43.7% |
Q3 2016 | $128,873,000 | +1467.6% | 3,921,889 | +1340.2% | 0.37% | +1445.8% |
Q2 2016 | $8,221,000 | -25.0% | 272,312 | -30.1% | 0.02% | -29.4% |
Q1 2016 | $10,966,000 | -3.8% | 389,420 | +16.0% | 0.03% | -5.6% |
Q4 2015 | $11,401,000 | +20.2% | 335,817 | +12.7% | 0.04% | +16.1% |
Q3 2015 | $9,484,000 | +86.8% | 298,046 | +274.1% | 0.03% | +106.7% |
Q2 2015 | $5,076,000 | -6.9% | 79,671 | 0.0% | 0.02% | -11.8% |
Q1 2015 | $5,452,000 | +35.4% | 79,671 | +39.2% | 0.02% | +41.7% |
Q4 2014 | $4,027,000 | -74.2% | 57,218 | -73.8% | 0.01% | -76.0% |
Q3 2014 | $15,597,000 | +949.6% | 218,321 | +991.6% | 0.05% | +900.0% |
Q2 2014 | $1,486,000 | -99.4% | 20,000 | -99.5% | 0.01% | -99.4% |
Q1 2014 | $249,068,000 | +2.3% | 3,838,900 | -6.4% | 0.83% | -1.3% |
Q4 2013 | $243,468,000 | +16.7% | 4,100,848 | +2.1% | 0.84% | +4.9% |
Q3 2013 | $208,622,000 | +19.6% | 4,017,377 | +8.9% | 0.80% | +16.5% |
Q2 2013 | $174,462,000 | – | 3,688,423 | – | 0.69% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |